Citigroup’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82K | Sell |
|
|||||
|
2025
Q1 | $7.14K | Sell |
|
|||||
|
2024
Q4 | $13K | Buy |
|
|||||
|
2024
Q3 | $20K | Buy |
|
|||||
|
2024
Q2 | $11.5K | Buy |
|
|||||
|
2024
Q1 | $13.3K | Buy |
|
|||||
|
2023
Q4 | $9.08K | Buy |
|
|||||
|
2023
Q3 | $1.63K | Sell |
|
|||||
|
2023
Q2 | $17.3K | Sell |
|
|||||
|
2023
Q1 | $403K | Buy |
|
|||||
|
2022
Q4 | $363K | Buy |
|
|||||
|
2022
Q3 | $56K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $12K | Sell |
|
|||||
|
2021
Q4 | $51K | Sell |
|
|||||
|
2021
Q3 | $758K | Sell |
|
|||||
|
2021
Q2 | $2.17M | Buy |
|
|||||
|
2021
Q1 | $2.63M | Buy |
|
|||||
|
2020
Q4 | $124K | Buy |
|